nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—gallbladder cancer	0.857	1	CbGaD
Acetylsalicylic acid—TP53—gall bladder—gallbladder cancer	0.00545	0.106	CbGeAlD
Acetylsalicylic acid—NFKBIA—gall bladder—gallbladder cancer	0.00536	0.105	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—gallbladder cancer	0.00282	0.055	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—gallbladder cancer	0.00277	0.0541	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—gallbladder cancer	0.00271	0.053	CbGeAlD
Acetylsalicylic acid—TP53—pancreas—gallbladder cancer	0.00251	0.049	CbGeAlD
Acetylsalicylic acid—NFKBIA—pancreas—gallbladder cancer	0.00247	0.0482	CbGeAlD
Acetylsalicylic acid—HSPA5—pancreas—gallbladder cancer	0.00242	0.0472	CbGeAlD
Acetylsalicylic acid—RPS6KA3—pancreas—gallbladder cancer	0.00206	0.0402	CbGeAlD
Acetylsalicylic acid—ALB—gall bladder—gallbladder cancer	0.00193	0.0376	CbGeAlD
Acetylsalicylic acid—TP53—liver—gallbladder cancer	0.0016	0.0312	CbGeAlD
Acetylsalicylic acid—NFKBIA—liver—gallbladder cancer	0.00157	0.0307	CbGeAlD
Acetylsalicylic acid—HSPA5—liver—gallbladder cancer	0.00154	0.0301	CbGeAlD
Acetylsalicylic acid—RPS6KA3—liver—gallbladder cancer	0.00131	0.0256	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—gallbladder cancer	0.00122	0.0239	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—gallbladder cancer	0.0012	0.0235	CbGeAlD
Acetylsalicylic acid—HSPA5—lymph node—gallbladder cancer	0.00118	0.023	CbGeAlD
Acetylsalicylic acid—PTGS2—gall bladder—gallbladder cancer	0.00105	0.0205	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymph node—gallbladder cancer	0.001	0.0196	CbGeAlD
Acetylsalicylic acid—IKBKB—liver—gallbladder cancer	0.000967	0.0189	CbGeAlD
Acetylsalicylic acid—SLC22A7—liver—gallbladder cancer	0.000938	0.0183	CbGeAlD
Acetylsalicylic acid—EDNRA—lymph node—gallbladder cancer	0.000817	0.016	CbGeAlD
Acetylsalicylic acid—IKBKB—lymph node—gallbladder cancer	0.000742	0.0145	CbGeAlD
Acetylsalicylic acid—PTGS1—epithelium—gallbladder cancer	0.000568	0.0111	CbGeAlD
Acetylsalicylic acid—ALB—liver—gallbladder cancer	0.000565	0.011	CbGeAlD
Acetylsalicylic acid—PTGS2—epithelium—gallbladder cancer	0.000543	0.0106	CbGeAlD
Acetylsalicylic acid—PTGS2—pancreas—gallbladder cancer	0.000483	0.00944	CbGeAlD
Acetylsalicylic acid—CYP2C19—liver—gallbladder cancer	0.000455	0.00888	CbGeAlD
Acetylsalicylic acid—ALB—lymph node—gallbladder cancer	0.000433	0.00846	CbGeAlD
Acetylsalicylic acid—CYP2C8—liver—gallbladder cancer	0.000397	0.00775	CbGeAlD
Acetylsalicylic acid—CYP2C9—liver—gallbladder cancer	0.000352	0.00689	CbGeAlD
Acetylsalicylic acid—ABCB1—epithelium—gallbladder cancer	0.000336	0.00656	CbGeAlD
Acetylsalicylic acid—PTGS2—liver—gallbladder cancer	0.000308	0.00601	CbGeAlD
Acetylsalicylic acid—ABCB1—pancreas—gallbladder cancer	0.000299	0.00584	CbGeAlD
Acetylsalicylic acid—PTGS1—lymph node—gallbladder cancer	0.000247	0.00482	CbGeAlD
Acetylsalicylic acid—PTGS2—lymph node—gallbladder cancer	0.000236	0.00461	CbGeAlD
Acetylsalicylic acid—ABCB1—liver—gallbladder cancer	0.00019	0.00372	CbGeAlD
Acetylsalicylic acid—ABCB1—lymph node—gallbladder cancer	0.000146	0.00285	CbGeAlD
Acetylsalicylic acid—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—gallbladder cancer	0.000133	0.00145	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.000132	0.00144	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—ERBB4—gallbladder cancer	0.000132	0.00144	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000131	0.00144	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—ERBB3—gallbladder cancer	0.000131	0.00143	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—ERBB2—gallbladder cancer	0.00013	0.00142	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—p75(NTR)-mediated signaling—TP53—gallbladder cancer	0.00013	0.00142	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000129	0.00142	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000129	0.00142	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—mTOR signaling pathway—HRAS—gallbladder cancer	0.000128	0.00141	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—gallbladder cancer	0.000128	0.00141	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—BCL2—gallbladder cancer	0.000128	0.0014	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—MAPK Signaling Pathway—TP53—gallbladder cancer	0.000128	0.0014	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Insulin Signaling—HRAS—gallbladder cancer	0.000127	0.00139	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—gallbladder cancer	0.000127	0.00139	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BCR signaling pathway—HRAS—gallbladder cancer	0.000127	0.00139	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000126	0.00138	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.000125	0.00137	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.000125	0.00137	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000122	0.00134	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—NRAS—gallbladder cancer	0.000122	0.00134	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—B Cell Activation—HRAS—gallbladder cancer	0.000121	0.00133	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—NRAS—gallbladder cancer	0.000118	0.0013	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000118	0.00129	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000118	0.00129	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular Senescence—TP53—gallbladder cancer	0.000118	0.00129	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—NRAS—gallbladder cancer	0.000117	0.00128	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Hemostasis—KRAS—gallbladder cancer	0.000116	0.00127	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Leptin signaling pathway—HRAS—gallbladder cancer	0.000116	0.00127	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—KRAS—gallbladder cancer	0.000116	0.00127	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—ERBB3—gallbladder cancer	0.000114	0.00125	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—ERBB4—gallbladder cancer	0.000114	0.00124	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.000112	0.00123	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—EGFR—gallbladder cancer	0.000111	0.00122	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis—TP53—gallbladder cancer	0.000111	0.00121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—gallbladder cancer	0.00011	0.0012	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—NRAS—gallbladder cancer	0.000109	0.0012	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000106	0.00117	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—EGFR—gallbladder cancer	0.000106	0.00116	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—KRAS—gallbladder cancer	0.000105	0.00115	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB2—gallbladder cancer	0.000105	0.00115	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000104	0.00114	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Apoptosis Modulation and Signaling—TP53—gallbladder cancer	0.000104	0.00114	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Hemostasis—TP53—gallbladder cancer	0.000103	0.00113	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—KRAS—gallbladder cancer	0.000102	0.00112	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.0001	0.0011	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.0001	0.0011	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—KRAS—gallbladder cancer	0.0001	0.0011	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TCR Signaling Pathway—HRAS—gallbladder cancer	0.0001	0.0011	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—EGFR—gallbladder cancer	9.95e-05	0.00109	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—NRAS—gallbladder cancer	9.89e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Hemostasis—HRAS—gallbladder cancer	9.86e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—TNF alpha Signaling Pathway—HRAS—gallbladder cancer	9.85e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ERBB4—gallbladder cancer	9.85e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—ERBB3—gallbladder cancer	9.82e-05	0.00108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—ERBB2—gallbladder cancer	9.7e-05	0.00106	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—BCL2—gallbladder cancer	9.56e-05	0.00105	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—NRAS—gallbladder cancer	9.46e-05	0.00104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Receptor Signaling Pathway—HRAS—gallbladder cancer	9.44e-05	0.00103	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—BCL2—gallbladder cancer	9.43e-05	0.00103	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—KRAS—gallbladder cancer	9.4e-05	0.00103	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—ERBB2—gallbladder cancer	9.29e-05	0.00102	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—ERBB2—gallbladder cancer	9.27e-05	0.00102	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KEAP1—gallbladder cancer	9.21e-05	0.00101	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—ERBB2—gallbladder cancer	9.16e-05	0.001	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—EGFR—gallbladder cancer	9.01e-05	0.000987	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—HRAS—gallbladder cancer	8.94e-05	0.00098	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—TP53—gallbladder cancer	8.91e-05	0.000977	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ERBB4—gallbladder cancer	8.8e-05	0.000965	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—ERBB2—gallbladder cancer	8.8e-05	0.000964	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—HRAS—gallbladder cancer	8.66e-05	0.00095	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HRAS—gallbladder cancer	8.53e-05	0.000934	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ERBB3—gallbladder cancer	8.51e-05	0.000933	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—KRAS—gallbladder cancer	8.51e-05	0.000933	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—BCL2—gallbladder cancer	8.43e-05	0.000924	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—gallbladder cancer	8.36e-05	0.000916	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—NRAS—gallbladder cancer	8.32e-05	0.000911	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—ERBB2—gallbladder cancer	8.19e-05	0.000898	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Neuronal System—HRAS—gallbladder cancer	8.15e-05	0.000894	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—KRAS—gallbladder cancer	8.14e-05	0.000892	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—HRAS—gallbladder cancer	7.99e-05	0.000876	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—gallbladder cancer	7.98e-05	0.000874	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—ERBB4—gallbladder cancer	7.95e-05	0.000871	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—NRAS—gallbladder cancer	7.65e-05	0.000839	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—gallbladder cancer	7.61e-05	0.000834	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ERBB3—gallbladder cancer	7.61e-05	0.000834	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—EGFR—gallbladder cancer	7.58e-05	0.00083	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—ERBB4—gallbladder cancer	7.51e-05	0.000824	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—NRAS—gallbladder cancer	7.38e-05	0.000809	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—gallbladder cancer	7.27e-05	0.000796	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—HRAS—gallbladder cancer	7.23e-05	0.000793	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ERBB4—gallbladder cancer	7.22e-05	0.000791	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	7.19e-05	0.000788	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—KRAS—gallbladder cancer	7.16e-05	0.000784	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—ERBB2—gallbladder cancer	7.14e-05	0.000783	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TP53—gallbladder cancer	7.1e-05	0.000778	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—NRAS—gallbladder cancer	7.07e-05	0.000775	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—NRAS—gallbladder cancer	7.06e-05	0.000773	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—NRAS—gallbladder cancer	6.97e-05	0.000764	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—HRAS—gallbladder cancer	6.92e-05	0.000758	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—HRAS—gallbladder cancer	6.88e-05	0.000754	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—ERBB3—gallbladder cancer	6.87e-05	0.000753	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	6.87e-05	0.000752	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—EGFR—gallbladder cancer	6.73e-05	0.000737	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—NRAS—gallbladder cancer	6.69e-05	0.000734	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	6.63e-05	0.000727	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—KRAS—gallbladder cancer	6.59e-05	0.000722	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—EGFR—gallbladder cancer	6.57e-05	0.00072	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—ERBB3—gallbladder cancer	6.5e-05	0.000712	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	6.44e-05	0.000706	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—EGFR—gallbladder cancer	6.44e-05	0.000706	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—EGFR—gallbladder cancer	6.43e-05	0.000705	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB4—gallbladder cancer	6.37e-05	0.000698	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—gallbladder cancer	6.36e-05	0.000697	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—KRAS—gallbladder cancer	6.35e-05	0.000696	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—EGFR—gallbladder cancer	6.35e-05	0.000696	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—HRAS—gallbladder cancer	6.33e-05	0.000693	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB4—gallbladder cancer	6.29e-05	0.00069	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ERBB3—gallbladder cancer	6.24e-05	0.000684	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—NRAS—gallbladder cancer	6.23e-05	0.000683	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—ERBB2—gallbladder cancer	6.15e-05	0.000675	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	6.11e-05	0.00067	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—EGFR—gallbladder cancer	6.1e-05	0.000668	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—KRAS—gallbladder cancer	6.08e-05	0.000667	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—KRAS—gallbladder cancer	6.07e-05	0.000666	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—KRAS—gallbladder cancer	6e-05	0.000658	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	5.84e-05	0.00064	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—KRAS—gallbladder cancer	5.76e-05	0.000631	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB4—gallbladder cancer	5.69e-05	0.000624	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB4—gallbladder cancer	5.69e-05	0.000624	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—EGFR—gallbladder cancer	5.68e-05	0.000622	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—HRAS—gallbladder cancer	5.6e-05	0.000614	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	5.53e-05	0.000606	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—gallbladder cancer	5.51e-05	0.000604	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB3—gallbladder cancer	5.5e-05	0.000603	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—BCL2—gallbladder cancer	5.49e-05	0.000602	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB3—gallbladder cancer	5.44e-05	0.000596	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—NRAS—gallbladder cancer	5.43e-05	0.000596	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—HRAS—gallbladder cancer	5.4e-05	0.000592	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—KRAS—gallbladder cancer	5.36e-05	0.000588	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ERBB2—gallbladder cancer	5.34e-05	0.000585	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HRAS—gallbladder cancer	5.17e-05	0.000567	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—HRAS—gallbladder cancer	5.16e-05	0.000566	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HRAS—gallbladder cancer	5.1e-05	0.000559	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—EGFR—gallbladder cancer	4.95e-05	0.000543	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB3—gallbladder cancer	4.92e-05	0.000539	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB3—gallbladder cancer	4.92e-05	0.000539	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—BCL2—gallbladder cancer	4.91e-05	0.000538	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HRAS—gallbladder cancer	4.9e-05	0.000537	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ERBB2—gallbladder cancer	4.77e-05	0.000523	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	4.76e-05	0.000521	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	4.7e-05	0.000515	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NRAS—gallbladder cancer	4.68e-05	0.000513	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—KRAS—gallbladder cancer	4.68e-05	0.000513	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	4.57e-05	0.000501	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HRAS—gallbladder cancer	4.56e-05	0.0005	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	4.47e-05	0.00049	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB4—gallbladder cancer	4.38e-05	0.00048	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—ERBB2—gallbladder cancer	4.31e-05	0.000472	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EGFR—gallbladder cancer	4.27e-05	0.000468	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	4.22e-05	0.000462	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—BCL2—gallbladder cancer	4.19e-05	0.00046	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—ERBB2—gallbladder cancer	4.07e-05	0.000446	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—NRAS—gallbladder cancer	4.06e-05	0.000445	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	4.04e-05	0.000443	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—KRAS—gallbladder cancer	4.03e-05	0.000442	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—HRAS—gallbladder cancer	3.98e-05	0.000436	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—NRAS—gallbladder cancer	3.97e-05	0.000435	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—NRAS—gallbladder cancer	3.97e-05	0.000435	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ERBB2—gallbladder cancer	3.91e-05	0.000429	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB3—gallbladder cancer	3.78e-05	0.000415	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	3.75e-05	0.000411	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EGFR—gallbladder cancer	3.7e-05	0.000405	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NRAS—gallbladder cancer	3.63e-05	0.000398	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EGFR—gallbladder cancer	3.62e-05	0.000397	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EGFR—gallbladder cancer	3.62e-05	0.000397	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—KRAS—gallbladder cancer	3.49e-05	0.000383	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB2—gallbladder cancer	3.45e-05	0.000378	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—gallbladder cancer	3.43e-05	0.000375	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—KRAS—gallbladder cancer	3.42e-05	0.000375	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—KRAS—gallbladder cancer	3.42e-05	0.000375	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB2—gallbladder cancer	3.41e-05	0.000374	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EGFR—gallbladder cancer	3.31e-05	0.000362	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NRAS—gallbladder cancer	3.28e-05	0.000359	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	3.17e-05	0.000347	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KRAS—gallbladder cancer	3.12e-05	0.000342	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NRAS—gallbladder cancer	3.1e-05	0.00034	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB2—gallbladder cancer	3.08e-05	0.000338	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB2—gallbladder cancer	3.08e-05	0.000338	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	2.99e-05	0.000328	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EGFR—gallbladder cancer	2.99e-05	0.000327	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NRAS—gallbladder cancer	2.98e-05	0.000326	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—gallbladder cancer	2.97e-05	0.000326	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—gallbladder cancer	2.91e-05	0.000319	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—gallbladder cancer	2.91e-05	0.000319	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB4—gallbladder cancer	2.83e-05	0.00031	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EGFR—gallbladder cancer	2.82e-05	0.000309	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KRAS—gallbladder cancer	2.82e-05	0.000309	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—EGFR—gallbladder cancer	2.71e-05	0.000297	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KRAS—gallbladder cancer	2.67e-05	0.000292	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	2.66e-05	0.000291	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—gallbladder cancer	2.66e-05	0.000291	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB4—gallbladder cancer	2.64e-05	0.000289	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NRAS—gallbladder cancer	2.63e-05	0.000288	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NRAS—gallbladder cancer	2.59e-05	0.000284	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KRAS—gallbladder cancer	2.56e-05	0.000281	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—gallbladder cancer	2.51e-05	0.000275	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB3—gallbladder cancer	2.45e-05	0.000268	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—BCL2—gallbladder cancer	2.44e-05	0.000268	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—gallbladder cancer	2.4e-05	0.000263	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—gallbladder cancer	2.39e-05	0.000262	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB2—gallbladder cancer	2.37e-05	0.00026	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—gallbladder cancer	2.36e-05	0.000259	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRAS—gallbladder cancer	2.35e-05	0.000257	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRAS—gallbladder cancer	2.35e-05	0.000257	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB3—gallbladder cancer	2.28e-05	0.00025	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—gallbladder cancer	2.27e-05	0.000248	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—gallbladder cancer	2.26e-05	0.000248	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—gallbladder cancer	2.23e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—gallbladder cancer	2.18e-05	0.000239	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—gallbladder cancer	2.14e-05	0.000234	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—gallbladder cancer	2.14e-05	0.000234	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—gallbladder cancer	2.02e-05	0.000221	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—gallbladder cancer	2.02e-05	0.000221	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—gallbladder cancer	2.01e-05	0.00022	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—gallbladder cancer	1.92e-05	0.00021	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—gallbladder cancer	1.9e-05	0.000208	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—gallbladder cancer	1.82e-05	0.000199	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—gallbladder cancer	1.81e-05	0.000198	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—gallbladder cancer	1.8e-05	0.000197	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—gallbladder cancer	1.8e-05	0.000197	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—gallbladder cancer	1.72e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—gallbladder cancer	1.72e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—gallbladder cancer	1.64e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—gallbladder cancer	1.57e-05	0.000172	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—gallbladder cancer	1.55e-05	0.00017	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—gallbladder cancer	1.53e-05	0.000168	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—gallbladder cancer	1.43e-05	0.000157	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—gallbladder cancer	1.39e-05	0.000153	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—gallbladder cancer	1.33e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—gallbladder cancer	1.32e-05	0.000145	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—gallbladder cancer	1.17e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—gallbladder cancer	1.09e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—gallbladder cancer	1.06e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—gallbladder cancer	1e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—gallbladder cancer	9.92e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—gallbladder cancer	9.37e-06	0.000103	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—gallbladder cancer	8.93e-06	9.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—gallbladder cancer	8.54e-06	9.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—gallbladder cancer	7.96e-06	8.73e-05	CbGpPWpGaD
